SLC1A2 and amyotrophic lateral sclerosis: The Trotti group at Thomas Jefferson revealed that the extent of sumoylated EAAT2 does not change during the course of ALS progression suggesting that sumoylation is not caused by pathological mechanisms in the SOD1-G93A mouse model (Foran et al., 2014).